产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 |
CAS No. |
2715120-86-6 |
|---|---|
中文名称 |
8-((3R,4S)-4-乙基-1-((2,2,2-三氟乙基)氨基甲酰基)吡咯烷-3-基)-N-(2,2,2-三氟乙基)-3H-咪唑并[1,2-a]吡咯并[2,3-e]吡嗪-3-甲酰胺 |
英文名称 |
8-((3R,4S)-4-Ethyl-1-((2,2,2-trifluoroethyl)carbamoyl)pyrrolidin-3-yl)-N-(2,2,2-trifluoroethyl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine-3-carboxamide |
别名 |
8-((3R,4S)-4-ethyl-1-((2,2,2-trifluoroethyl)carbamoyl)pyrrolidin-3-yl)-N-(2,2,2-trifluoroethyl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine-3-carboxamide;Upatinib impurity G;Ubatinib Impurity 08;Dienogest Impurity 30;(3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)pyrrolidine-1-carboxylic acid;A-1666715.0;RMA-866 |
标准英文名 |
8-((3R,4S)-4-ethyl-1-((2,2,2-trifluoroethyl)carbamoyl)pyrrolidin-3-yl)-N-(2,2,2-trifluoroethyl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine-3-carboxamide |
分子式 |
C20H21F6N7O2 |
分子量 |
505.42 |
精确分子量 |
505.17 |
SMILES |
CC[C@H]1[C@H](CN(C1)C(NCC(F)(F)F)=O)C2=CN=C3C=NC(N(C=C4)C(NCC(F)(F)F)=O)=C4N23 |
标准SMILES |
CC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3C(=O)NCC(F)(F)F)N21)C(=O)NCC(F)(F)F |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes.Not for drug or household use. |
信号词 |
Warning |
InChIKey |
WHRQTFAKBJNQRU-NEPJUHHUSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Sealed in dry, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral(Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation(Category 2A),Specific target organ toxicity, single exposure;Respiratory system(Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|